Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Cost considerations Pharmaceutical semaglutide (Wegovy): $1,300-1,500/month without insurance Insurance may cover (varies) Patient assistance programs available Research semaglutide: $150-300/month No insurance No patient assistance User assumes risk Research cagrilintide: $200-400/month Not prescription available yet Higher cost due to limited availability Total CagriSema combination cost (research chemicals): $350-700/month Both peptides at full dose Significant investment Compare to bariatric surgery ($15,000-25,000 upfront) Budget planning: Year 1 (titration + maintenance): $4,200-8,400 Ongoing maintenance: $350-700/month Consider reducing to maintenance doses May need 12-24+ months total Use our peptide cost calculator to budget protocols
Chez MG, Chang M, Krasne V, Coughlan C, Kominsky M, Schwartz A
How Will the BALANCE Model Work
AbbVie, which paid $350 million to license a long-acting amylin analog from the firm Gubra, also recently announced Phase 1 data
This could be because GLP-1 patients lose some of the fat where adipose-derived stem cells reside: Its called dermal white adipose tissue, and it comprises little niblets of fat within the dermisits previously underappreciated fat, explains Saami Khalifian, MD, a board-certified dermatologist in Encinitas, California
US$ 20.94
US$ 28.55
US$ 27.59
